These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27846627)

  • 61. The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis.
    Heo WI; Lee KE; Hong JY; Kim MN; Oh MS; Kim YS; Kim KW; Kim KE; Sohn MH
    Clin Exp Dermatol; 2015 Aug; 40(6):665-71. PubMed ID: 25684357
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.
    Moy AP; Murali M; Kroshinsky D; Duncan LM; Nazarian RM
    JAMA Dermatol; 2015 Jul; 151(7):753-60. PubMed ID: 25760640
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.
    Skabytska Y; Kaesler S; Volz T; Biedermann T
    Semin Immunopathol; 2016 Jan; 38(1):29-43. PubMed ID: 26573298
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of Acer tegmentosum bark on atopic dermatitis-like skin lesions in NC/Nga mice.
    Yang G; An D; Lee MH; Lee K; Kim B; Suman CK; Ham I; Choi HY
    J Ethnopharmacol; 2016 Jan; 177():53-60. PubMed ID: 26619913
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Future treatment options for atopic dermatitis - small molecules and beyond.
    Schäkel K; Döbel T; Bosselmann I
    J Dermatol Sci; 2014 Feb; 73(2):91-100. PubMed ID: 24360854
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults.
    Renert-Yuval Y; Del Duca E; Pavel AB; Fang M; Lefferdink R; Wu J; Diaz A; Estrada YD; Canter T; Zhang N; Wagner A; Chamlin S; Krueger JG; Guttman-Yassky E; Paller AS
    J Allergy Clin Immunol; 2021 Jul; 148(1):148-163. PubMed ID: 33453290
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A novel mouse model of atopic dermatitis with epicutaneous allergen sensitization and the effect of Lactobacillus rhamnosus.
    Kim HJ; Kim YJ; Kang MJ; Seo JH; Kim HY; Jeong SK; Lee SH; Kim JM; Hong SJ
    Exp Dermatol; 2012 Sep; 21(9):672-5. PubMed ID: 22742655
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Allergen-induced Th1 and Th2 cytokine secretion in relation to specific allergen sensitization and atopic symptoms in children.
    Jenmalm MC; Van Snick J; Cormont F; Salman B
    Clin Exp Allergy; 2001 Oct; 31(10):1528-35. PubMed ID: 11678852
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Targeting cytokines and signaling molecules related to immune pathways in atopic dermatitis: therapeutic implications and challenges.
    Kim HO
    Arch Pharm Res; 2022 Dec; 45(12):894-908. PubMed ID: 36462097
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.
    Hamilton JD; Suárez-Fariñas M; Dhingra N; Cardinale I; Li X; Kostic A; Ming JE; Radin AR; Krueger JG; Graham N; Yancopoulos GD; Pirozzi G; Guttman-Yassky E
    J Allergy Clin Immunol; 2014 Dec; 134(6):1293-1300. PubMed ID: 25482871
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents.
    Tanimoto A; Shinozaki Y; Yamamoto Y; Katsuda Y; Taniai-Riya E; Toyoda K; Kakimoto K; Kimoto Y; Amano W; Konishi N; Hayashi M
    Exp Dermatol; 2018 Jan; 27(1):22-29. PubMed ID: 28423239
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Solanum tuberosum L. cv Jayoung Epidermis Extract Inhibits Mite Antigen-Induced Atopic Dermatitis in NC/Nga Mice by Regulating the Th1/Th2 Balance and Expression of Filaggrin.
    Yang G; Cheon SY; Chung KS; Lee SJ; Hong CH; Lee KT; Jang DS; Jeong JC; Kwon OK; Nam JH; An HJ
    J Med Food; 2015 Sep; 18(9):1013-21. PubMed ID: 26102094
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.
    Brunner PM; Guttman-Yassky E; Leung DY
    J Allergy Clin Immunol; 2017 Apr; 139(4S):S65-S76. PubMed ID: 28390479
    [TBL] [Abstract][Full Text] [Related]  

  • 74. JAK Inhibitors for Atopic Dermatitis: An Update.
    He H; Guttman-Yassky E
    Am J Clin Dermatol; 2019 Apr; 20(2):181-192. PubMed ID: 30536048
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Baicalin ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice through modulating skin barrier function, gut microbiota and JAK/STAT pathway.
    Wang L; Xian YF; Loo SKF; Ip SP; Yang W; Chan WY; Lin ZX; Wu JCY
    Bioorg Chem; 2022 Feb; 119():105538. PubMed ID: 34929516
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antagonistic effect of the inflammasome on thymic stromal lymphopoietin expression in the skin.
    Schuepbach-Mallepell S; Philippe V; Brüggen MC; Watanabe H; Roques S; Baldeschi C; Gaide O
    J Allergy Clin Immunol; 2013 Dec; 132(6):1348-57. PubMed ID: 23953709
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation.
    Seshasayee D; Lee WP; Zhou M; Shu J; Suto E; Zhang J; Diehl L; Austin CD; Meng YG; Tan M; Bullens SL; Seeber S; Fuentes ME; Labrijn AF; Graus YM; Miller LA; Schelegle ES; Hyde DM; Wu LC; Hymowitz SG; Martin F
    J Clin Invest; 2007 Dec; 117(12):3868-78. PubMed ID: 18060034
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immune dysregulation and Th2 polarization are associated with atopic dermatitis in heart-transplant children: A delicate balance between risk of rejection or atopic symptoms.
    López-Abente J; Bernaldo-de-Quirós E; Camino M; Gil N; Panadero E; Campos-Domínguez M; Seoane-Reula E; Gil-Jaurena JM; Pion M; Correa-Rocha R
    Am J Transplant; 2019 May; 19(5):1536-1544. PubMed ID: 30614192
    [TBL] [Abstract][Full Text] [Related]  

  • 79. TSLP as druggable target - a silver-lining for atopic diseases?
    Adhikary PP; Tan Z; Page BDG; Hedtrich S
    Pharmacol Ther; 2021 Jan; 217():107648. PubMed ID: 32758645
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of Lactobacillus rhamnosus on allergic march model by suppressing Th2, Th17, and TSLP responses via CD4(+)CD25(+)Foxp3(+) Tregs.
    Kim HJ; Kim YJ; Lee SH; Yu J; Jeong SK; Hong SJ
    Clin Immunol; 2014 Jul; 153(1):178-86. PubMed ID: 24769377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.